• 1
    Sporn MB, Dunlop NM, Newton DL et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976; 35: 13328.
  • 2
    Sporn MB. Combination chemoprevention of cancer. Nature 1980; 287: 1078.
  • 3
    Fujiki H, Suganuma M. Green tea and cancer prevention. Proc Jpn Acad 2002; 78: 26370.
  • 4
    Fujiki H, Suganuma M, Imai K et al. Green tea: cancer preventive beverage and/or drug. Cancer Lett 2002; 188: 913.
  • 5
    Fujiki H. Green tea: health benefits as cancer preventive for humans. Chem Rec 2005; 5: 11932.
  • 6
    Suganuma M, Okabe S, Kai Y et al. Synergistic effects of (−)-epigallocatechin gallate with (−)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 1999; 59: 447.
  • 7
    Shimizu M, Fukutomi Y, Ninomiya M et al. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev 2008; 17: 30205.
  • 8
    Suganuma M, Kurusu M, Suzuki K et al. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int J Cancer 2006; 119: 3340.
  • 9
    Suganuma M, Ohkura Y, Okabe S et al. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J Cancer Res Clin Oncol 2001; 127: 6972.
  • 10
    Fujiki H, Suganuma M, Kurusu M et al. New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Mutat Res 2003; 524: 11925.
  • 11
    Saha A, Kuzuhara T, Echigo N et al. Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of “growth arrest and DNA damage inducible genes 45 and 153”. Biol Pharm Bull 2010; 33: 12919.
  • 12
    Anand P, Sundaram C, Jhurani S et al. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett 2008; 267: 13364.
  • 13
    Saha A, Kuzuhara T, Echigo N et al. New role of (−)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin. Cancer Prev Res 2010; 3: 95362.
  • 14
    Masuda M, Suzui M, Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2001; 7: 42209.
  • 15
    Masuda M, Suzui M, Lim JT et al. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 2003; 9: 348691.
  • 16
    Tasaki E, Suenaga M, Yamanaka H et al. Enhancement of effects by cotreatment with two tyrosine kinase inhibitors, IRESSA and tea polyphenol EGCG. Proc Jpn Cancer Assoc 2004; 63: 477.
  • 17
    Fisher B, Powles TJ, Pritchard KJ. Tamoxifen for the prevention of breast cancer. Eur J Cancer 2000; 36: 14250.
  • 18
    Komori A, Yatsunami J, Suganuma M et al. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 1993; 53: 19825.
  • 19
    Fujiki H, Suganuma M. Tumor necrosis factor-α, a new tumor promoter, engendered by biochemical studies of okadaic acid. J Biochem 1994; 115: 15.
  • 20
    Suganuma M, Okabe S, Marino MW et al. Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res 1999; 59: 45168.
  • 21
    Sakata M, Ikeda T, Imoto S et al. Influence of green tea extract and tamoxifen on murine mammary carcinogenesis and estrogen metabolism. Proc Jpn Cancer Asssoc 1995; 54: 128.
  • 22
    Chisholm K, Bray BJ, Rosengren RJ. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 2004; 15: 88997.
  • 23
    Sartippour MR, Pietras R, Marquez-Garban DC et al. The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 2006; 27: 242433.
  • 24
    Kelloff GJ, Crowell JA, Hawk ET et al. Strategy and planning for chemopreventive drug development: clinical development plans II. J Cell Biochem Suppl 1996; 26S: 5471.
  • 25
    Suganuma M, Sueoka E, Sueoka N et al. Mechanisms of cancer preventin by tea polyphenols based on inhibition of TNF-α expression. BioFactors 2000; 13: 672.
  • 26
    Ohishi T, Kishimoto Y, Miura N et al. Synergistic effects of (−)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane. Cancer Lett 2002; 177: 4956.
  • 27
    Chalifour LE, Fahmy R, Holder EL et al. A method for analysis of gene expression patterns. Anal Biochem 1994; 216: 299304.
  • 28
    Okabe S, Fujimoto N, Sueoka N et al. Modulation of gene expression by (−)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol Pharm Bull 2001; 24: 8836.
  • 29
    Novoa I, Zeng H, Harding HP et al. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 2001; 153: 101122.
  • 30
    Lu YP, Lou YR, Li XH et al. Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice. Cancer Res 2000; 60: 478591.
  • 31
    Arber N, Eagle CJ, Spicak J et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006; 355: 88595.
  • 32
    Suganuma M, Takahashi A, Watanabe T et al. Up-regulation of GADD153 gene related ER stress by EGCG and alkyl gallate: a unique lung cancer prevention biomarker. Proc Jpn Cancer Assoc 2009; 68: 496.
  • 33
    Adhami VM, Malik A, Zaman N et al. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 2007; 13: 16119.
  • 34
    Ron D, Habener JF. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 1992; 6: 43953.
  • 35
    Maytin EV, Ubeda M, Lin JC et al. Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp Cell Res 2001; 267: 193204.
  • 36
    Bogos K, Renyi-Vamos F, Kovacs G et al. Role of retinoic receptors in lung carcinogenesis. J Exp Clin Cancer Res 2008; 27: 118.
  • 37
    Suganuma M, Minato T, Misawa A et al. New approach to lung cancer prevnetion mediated through up-regulation of GADD153 gene. Proc Am Assoc Cancer Res 2008; 49: 726.
  • 38
    Khafif A, Schantz SP, Chou TC et al. Quantitation of chemopreventive synergism between (−)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 1998; 19: 41924.
  • 39
    Somers-Edgar TJ, Scandlyn MJ, Stuart EC et al. The combination of epigalocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo. Int J Cancer 2008; 22: 196671.
  • 40
    Aggawal BB, Kumar A, Aggawal MS, Shishodia S. Curcuin derived from turmeric (Curcuma longa): a spice for all seasons. In: BagchiD, PreussHG, eds. Phytopharmaceuticals in Cancer Chemoprevention. New York, NY: CRC press, 2005; 34987.
  • 41
    Liang G, Tang A, Lin X et al. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 2010; 37: 11123.
  • 42
    Yoshizawa S, Horiuchi T, Suganuma M et al. Penta-O-galloyl-β-d-glucose and (−)-epigallocatechin gallate. ACS Symp Ser 1992; 507: 31625.
  • 43
    Liang YC, Lin-shiau SY, Chen CF et al. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem 1997; 67: 5565.
  • 44
    Zhang X, Zhang H, Tighiouart M et al. Synergistic inhibition of head and neck tumor growth by green tea (−)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor. Int J Cancer 2008; 123: 100514.
  • 45
    Bettuzzi S, Brausi M, Rizzi F et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006; 66: 123440.
  • 46
    Tsao AS, Liu D, Martin J et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res 2009; 2: 93141.